Headlines

There are several areas of litigation worth keeping an eye on over the year ahead, with five in particular we’re working on that stand out to me in large part due to the urgent consumer and public health needs they hope to address. I’ve listed these five below, including my take on why they are noteworthy.

Fiat Chrysler Automobiles (FCA) has agreed to resolve allegations that it installed software to cheat emissions tests in certain diesel vehicles for model years 2014 to 2016.

Action may be needed to protect the public from health risks allegedly caused by talcum powder in certain cosmetic products, Canada’s health ministry announced.

We are proud to announce that legal publication South Carolina Lawyers Weekly included co-founding member Joe Rice in its inaugural 2018 Hall of Fame.

Motley Rice ranked as a National Tier 1 firm for Mass Tort Litigation / Class Actions – Plaintiffs, the highest rating for a firm in the 2019 edition of U.S. News – Best Lawyers® “Best Law Firms.”

The FDA announced plans to “modernize” its fast-tracked 510(k) approval program for medical devices. Currently, this program doesn’t require clinical trials for new products that it believes are similar enough to previously approved devices to justify quickly placing them on the market.

Settlement funds provided by Volkswagen following the automaker’s “Clean Diesel” emissions scandal will help improve air quality and decrease NOx emissions throughout South Carolina by funding upgrades to school buses and other public transportation.

Three Motley Rice attorneys were recognized as 2018 Connecticut Super Lawyers® and Rising Stars.

A California appellate panel ordered that claims alleging pancreatic cancer caused by diabetes drug manufacturers Merck & Co., Eli Lilly & Co., AstraZeneca’s Amylin Pharmaceuticals, and Novo Nordisk Inc., should move forward in state court.

Six Motley Rice attorneys are 2018 Rhode Island and New York Metro Super Lawyers® and Rising Stars.